CommentaryTriple oral therapy for type 2 diabetes
References (21)
- et al.
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study
Clin. Ther.
(2005 Oct) Insulin as initial therapy for type 2 diabetes is not in the patient's best interest
Endocr. Pract.
(2004 May-Jun)- et al.
Triple oral antidiabetic therapy in type 2 diabetes mellitus
Endocr. Pract.
(1998) - et al.
Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control
Endocr. Pract.
(2000) - et al.
Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice
Endocr. Pract.
(2000) - et al.
Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial
Am. J. Med.
(2004) - et al.
Long-term efficacy of triple oral therapy for type 2 diabetes mellitus
Endocr. Pract.
(2002) - et al.
Insulin infusion in acute illness
J. Clin. Invest.
(2005) - et al.
GLAI Study Investigators. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
Diabetes Care
(2005) Early insulin: an important therapeutic strategy
Diabetes Care
(2005)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2007 Elsevier Ireland Ltd. All rights reserved.